Mechano-Chemical Endovenous Ablation of Great Saphenous Vein Insufficiency: Two-Year Results

2014 ◽  
Vol 23 (3) ◽  
pp. 176-179 ◽  
Author(s):  
Yücel ÖZEN ◽  
Davut ÇEKMECELİOĞLU ◽  
Sabit SARIKAYA ◽  
Murat Bülent RABUŞ ◽  
Ebuzer AYDIN ◽  
...  
2014 ◽  
Vol 2 (3) ◽  
pp. 282-288 ◽  
Author(s):  
Ramon R.J.P. van Eekeren ◽  
Doeke Boersma ◽  
Suzanne Holewijn ◽  
Debora A.B. Werson ◽  
Jean Paul P.M. de Vries ◽  
...  

2008 ◽  
Vol 48 (3) ◽  
pp. 675-679 ◽  
Author(s):  
Xinwu Lu ◽  
Kaichuang Ye ◽  
Weimin Li ◽  
Min Lu ◽  
Xintian Huang ◽  
...  

2013 ◽  
Vol 29 (10) ◽  
pp. 654-657 ◽  
Author(s):  
Leo P Sullivan ◽  
Giang Quach ◽  
Tina Chapman

Objective To present the use of retrograde mechanico-chemical endovenous ablation for ablating the remaining below-knee great saphenous vein in patients with venous stasis ulcers persisting after above-knee great saphenous vein ablation. Methods This small study includes six patients with persistent C6EpAsPr ulcers following above-knee great saphenous vein ablation with no incompetent perforators. They were treated using retrograde mechanico-chemical endovenous ablation approach followed by Unna therapy, followed up on post op days 3 and 30 with ultrasound, and subsequent weekly visits until the wound healed. Results Six patients (four men and two women), have average ulcer size of 4.1 cm2. There was no nerve injury or other complications after mechanico-chemical endovenous ablation. These patients had an average of 28 ± 11 days healing time, compared with a mean of five months in traditional method. Conclusion Mechanico-chemical endovenous ablation can be safe and effective in the treatment of patients with below-knee great saphenous vein insufficiency with venous ulcers.


2016 ◽  
Vol 32 (1) ◽  
pp. 6-12 ◽  
Author(s):  
TY Tang ◽  
JW Kam ◽  
ME Gaunt

Objectives This study assessed the effectiveness and patient experience of the ClariVein® endovenous occlusion catheter for varicose veins from a large single-centre series in the UK. Methods A total of 300 patients (371 legs) underwent ClariVein® treatment for their varicose veins; 184 for great saphenous vein (GSV) incompetence, 62 bilateral GSV, 23 short saphenous vein (SSV), 6 bilateral SSV and 25 combined unilateral great saphenous vein and SSV. Patients were reviewed at an interval of two months post procedure and underwent Duplex ultrasound assessment. Postoperative complications were recorded along with patient satisfaction. Results All 393 procedures were completed successfully under local anaesthetic. Complete occlusion of the treated vein was initially achieved in all the patients, but at eight weeks’ follow-up, there was only partial obliteration in 13/393 (3.3%) veins. These were all successfully treated with ultrasound-guided foam sclerotherapy. Procedures were well tolerated with a mean pain score of 0.8 (0–10). No significant complications were reported. Conclusions ClariVein® can be used to ablate long and short saphenous varicose veins on a walk-in–walk-out basis. Bilateral procedures can be successfully performed, and these are well tolerated as can multiple veins in the same leg. Early results are promising but further evaluation and longer term follow-up are required.


Sign in / Sign up

Export Citation Format

Share Document